首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   102070篇
  免费   7466篇
  国内免费   325篇
耳鼻咽喉   1354篇
儿科学   2592篇
妇产科学   2353篇
基础医学   12766篇
口腔科学   2099篇
临床医学   10023篇
内科学   22150篇
皮肤病学   1091篇
神经病学   8800篇
特种医学   3421篇
外国民族医学   3篇
外科学   16700篇
综合类   1453篇
现状与发展   1篇
一般理论   75篇
预防医学   8243篇
眼科学   2673篇
药学   6586篇
中国医学   142篇
肿瘤学   7336篇
  2023年   382篇
  2022年   468篇
  2021年   1695篇
  2020年   915篇
  2019年   1645篇
  2018年   1963篇
  2017年   1445篇
  2016年   1587篇
  2015年   1889篇
  2014年   2799篇
  2013年   4408篇
  2012年   6308篇
  2011年   6597篇
  2010年   3687篇
  2009年   3415篇
  2008年   6219篇
  2007年   6933篇
  2006年   6613篇
  2005年   6774篇
  2004年   6623篇
  2003年   6225篇
  2002年   6219篇
  2001年   876篇
  2000年   675篇
  1999年   860篇
  1998年   1300篇
  1997年   1166篇
  1996年   980篇
  1995年   992篇
  1994年   859篇
  1993年   767篇
  1992年   627篇
  1991年   567篇
  1990年   489篇
  1989年   520篇
  1988年   472篇
  1987年   501篇
  1986年   506篇
  1985年   558篇
  1984年   737篇
  1983年   782篇
  1982年   990篇
  1981年   932篇
  1980年   881篇
  1979年   484篇
  1978年   553篇
  1977年   602篇
  1976年   506篇
  1975年   429篇
  1973年   366篇
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
101.
Intractable tinnitus can lead to serious consequences. Study evidence indicates that the central nervous system is involved in generation and maintenance of chronic tinnitus and that tinnitus and other neurologic symptoms such as chronic pain may share similar mechanisms. Brain ablation and stimulation are used to treat chronic pain with success. Recent studies showed that ablation and stimulation in non-auditory areas resulted in tinnitus improvement. Deep brain stimulation (DBS) may be an alternative treatment for intractable tinnitus and deserves further study.  相似文献   
102.
Complement is a multifunctional system of receptors and regulators as well as effector molecules. Both the pathogenic and diagnostic power of complement is based on the capacity of the complement system to amplify innate and adaptive immunity. This amplification is accomplished through two strategies: (1) enzymatic reactions in the complement cascade, and (2) stimulation of leukocytes, platelets and parenchymal cells through specific receptors or receptor-independent pore formation. The mechanisms by which complement mediates and modifies nonspecific inflammation, antibody-mediated injury and T-cell responses are of particular significance to the pathogenesis of transplant rejection. Understanding the mechanisms by which complement integrates the interactions of leukocytes, platelets and parenchymal cells offers opportunities to further refine the diagnosis of rejection.  相似文献   
103.
104.
105.
Objective Approximately 10% of patients with neurofibromatosis I (NFI) patients will have central nervous system (CNS) tumors. The most common of these are hypothalamic–optic gliomas, followed by brainstem and cerebellar pilocytic astrocytomas. While isolated pilocytic astrocytomas in NFI are well described, the appearance of multiple pilocytic astrocytomas in an individual patient is less common. The most frequent combination in NFI patients with more than one pilocytic astrocytoma is optic tract/hypothalamic and brainstem. Other combinations are exceedingly rare; multiple pilocytic astrocytomas have only been reported once in the cerebral hemispheres in a patient with NFI. This report presents the first documented case, to our knowledge, of multiple pilocytic astrocytomas in the cerebellum of a patient with NF1. Methods Case report. Conclusion The finding of multiple cerebellar pilocytic astrocytomas in a patient with NF1 is important because it expands the spectrum of presentations for patients with NF1 and also highlights specific diagnostic and therapeutic challenges faced by the treating physicians. The genetic and molecular basis of NF1 is reviewed. Strategies of diagnosis and treatment outlined here are relevant to both patients with NF1 and all patients with multiple posterior fossa tumors.  相似文献   
106.
Multiple options exist for the prevention of deep vein thrombosis (DVT) in medical inpatients. We sought to determine the cost-effectiveness of low-molecular-weight heparin (LMWH) relative to unfractionated heparin (UFH) for DVT prevention in this setting. We conducted a cost-effectiveness analysis from the perspective of a third-party payer employing a decision model and literature-based estimates for inputs. In the base-case analysis, LMWH had little impact on the rate of DVT. Despite higher acquisition costs, however, LMWHs resulted in net savings. Routine use of LMWH saves approximately US$89 per patient. The lower rate of heparin-induced thrombocytopenia (HIT) with LMWH accounted for this differential. Univariate sensitivity analysis revealed the model was moderately sensitive to the odds ratio of HIT with LMWH and the cost of HIT. Multivariate sensitivity analysis confirmed the LMWH approach dominated financially. 'Worst-case' scenario modeling, where LMWH actually increased the risk for DVT, had little effect on the rate of HIT, and was substantially more costly than UFH, still demonstrated that LMWHs were economically superior. Monte-Carlo simulation indicated the 95% confidence interval around the estimate for savings with LMWH ranged from US$7 to US$373. We conclude that, despite their higher cost, LMWHs for thromboprophylaxis in medical patients result in savings.  相似文献   
107.
108.
109.
110.
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号